Galenus Precision Pharmacy, Inc. — SEC Form D Filing
Galenus Precision Pharmacy, Inc. filed an SEC Form D on February 18, 2026, reporting $1.94M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- February 18, 2026
- Amount reported
- $1.94M
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://galenuscare.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Adverse drug events lead to significant health issues and high costs in healthcare.
Solution
GalenusRx personalizes medication regimens and analyzes drug interactions to enhance safety and reduce costs.
Why now
There is a growing demand for personalized healthcare solutions to minimize adverse drug events.
Verdict
Investors said yes because Galenus Precision Pharmacy offered a timely solution to the pressing issue of adverse drug events, not because it presented a unique technological edge over competitors. They were implicitly betting on the increasing urgency for personalized healthcare solutions to mitigate risks in medication management while recognizing that the market is still prone to technology-related failures. The limited upside lies in a crowded field where similar innovations exist, suggesting that differentiators may not provide sustainable long-term value.
Source: SEC EDGAR Form D filing